HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.

TSX:HLS - Post by User

HLS Therapeutics Inc

Bullboard Posts

Post by jwarner-smithon Mar 22, 2012 8:07am

211 Views

Post# 19703909

P/E 3.5?

Just looking at Automodular's latest numbers. Net Profit Margin over 15%. Return on Equity of over 37%. Interest coverage of 46.2! This thing is trading at 3.6 x earnings even though the earnings tripled this year after doubling the year before. If this traded at what the rest of this industry traded at, which is 9.5 x earnings this would be a $5.80 stock. Get in while you can!

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages